Quality of life in depressed patients: Comparison of fluoxetine and major tricyclic antidepressants

International Clinical Psychopharmacology

Volumn 11, Issue 1, 1996, Pages 45-52

  Souetre E ^a,c   Martin, P ^a   Lozet, H ^a   Monteban, H ^b  

^a Benefit Research Group   (France)

^b Benefit Research Group   (Netherlands)

^c Benefit Research Group   (United States)

Author keywords

antidepressants; depression; quality of life

Indexed keywords

AMITRIPTYLINE; CLOMIPRAMINE; FLUOXETINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY OF LIFE; SOCIAL STATUS;

EID: 0029879140     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-199603000-00006     Document Type: Article

References (53)

1. Agosti V, Stewart JW et al. (1991) Life satisfaction and psychosocial functioning in chronic depression: effect of acute treatment with antidepressants. Journal of Affective Disorders, 23, 35-41.
2. Beuzen JN, Ravily VF, Souêtre E et al. (1993) Impact of fluoxetine on work loss in depression. International Clinical Psychopharmacology, 8, 319-321.
3. Blumenthal MD and Dielman TE (1975) Depressive symptomatology and role function in a general population. Archives of General Psychiatry, 32, 985-991.
4. Bombardier C, Ware J, Russell IJ et al. (1986) Auranofin therapy and quality of life in patients with rheumatoid arthritis. Results of a multicenter trial. American Journal of Medicine, 81, 565-578.
5. Broadhead WE, Blazer DG, George LK et al. (1990) Depression, disability days, and days lost from work in a prospective epidemiologic survey. Journal of the American Medical Association, 264, 2524-2528.
6. Bronisch T and Hecht H (1990) Major depression with and without a coexisting anxiety disorder: social dysfunction, social integration, and personality features. Journal of Affective Disorders, 20, 151-157.
7. Bulpitt CJ and Fletcher AE (1994) Quality of life instruments in hypertension. Pharmacoeconomics, 6, 523-535.
8. Cookson J (1993) Side-effects of antidepressants. British Journal of Psychiatry, 163 (Suppl 20), 20-24.
9. Craig TJ and Van Natta PA (1983) Disability and depressive symptoms in two communities. American Journal of Psychiatry, 140, 598-601.
10. Croog SH, Levine S, Testa MA et al. (1986) The effects of antihypertensive therapy on the quality of life. New England Journal of Medicine, 314, 1657-1664.
11. Deyo RA (1984) Measuring functional outcomes in therapeutic trials for chronic disease. Controlled Clinical Trials, 5, 223-240.
12. Feinstein AR (Ed.) (1985) Clinical Epidemiology - The Architecture of Clinical Research. WB Saunders Company, Philadelphia.
13. Feinstein AR, Josephy BR and Wells CK (1986) Scientific and clinical problems in indexes of functional disability. Annals of Internal Medicine, 105, 413-420.
14. Frerichs RR, Aneshensel CS, Yokopenic PA et al. (1982) Physical health and depression: an epidemiologic survey. Preventive Medicine, 11, 639-646.
15. Fries J and Spitz P (1990) The hierarchy of patient outcomes. In: Quality of Life Assessments in Clinical Trials (Ed. B Spilker), pp. 25-36. Raven Press, New York.
16. Gram L (1994) Fluoxetine. New England Journal of Medicine, 331, 1354-1361.
17. Hamilton M (1967) Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology, 6, 278-296.
18. Harrison G (1994) New or old antidepressants? New is better. British Medical Journal, 309, 1280-1281.
19. Hecht H, von Zerssen D, Kreig C et al. (1989) Anxiety and depression: co-morbidity, psychopathology and social functioning. Comprehensive Psychiatry, 30, 420-433.
20. Henry JA (1993) Debits and credits in the management of depression. British Journal of Psychiatry, Suppl 20, 33-39.
21. INSEE (1991) Recencement général de la population. Démographie-société. Institut National de la Statistique et des Etudes Economique, Paris.
22. Jenike MA, Baer L and Greist JH (1990) Clomipramine versus fluoxetine in obsessive-compulsive disorder: a retrospective comparison of side effects and efficacy. Journal of Clinical Psychopharmacology, 10, 122-124.
23. Kasper S, Fuger J and Moller HJ (1992) Comparative efficacy of antidepressants. Drugs, 43 (Suppl 2), 11-22.
24. Katon W, Von Korff M, Lin E et al. (1992) Adequacy and duration of antidepressant treatment in primary care. Medical Care, 30, 67-76.
25. Klerman GL (1989) Depressive disorders: further evidence for increased medical morbidity and impairment of social functioning. Archives of General Psychiatry, 46, 856-858.
26. Kocsis JH, Frances AJ, Voss C et al. (1988) Imipramine and social-vocational adjustment in chronic depression. American Journal of Psychiatry, 145, 997-999.
27. Kramer MS (1988) Clinical Epidemiology and Biostatistics: a Primer for Clinical Investigators and Decision-makers. Springer-Verlag, New York.
28. Lehman AF, Ward NC, Linn LS et al (1982) Chronic mental patients: the quality of life issue. American Journal of Psychiatry, 139, 1271-1276.
29. Lonnqvist J, Sintonen H, Syvalahti E et al. (1994) Antidepressant efficacy and quality of life in depression: a double-blind study with moclobemide and fluoxetine. Acta Psychiatrica Scandinavica, 89, 363-369.
30. Lyons RA, Lo SV and Littlepage BN (1994) Comparative health status of patients with 11 common illnesses in Wales. Journal of Epidemiology and Community Health, 48, 388-390.
31. Maguire P and Selby P (1989) Assessing quality of life in cancer patients. British Journal of Cancer, 60, 437-440.
32. Montgomery SA, Henry J, McDonald G et al. (1994) Selective serotonin reuptake inhibitors: meta-analysis of discontinuation rates. International Clinical Psychopharmacology, 9, 47-53.
33. Nelson EC and Berwick DM (1989) The measurement of health status in clinical practice. Medical Care, 27 (Suppl 3), 77-90.
34. Nierenberg AA (1994) The treatment of severe depression: is there an efficacy gap between SSRI and TCA antidepressant generations? Journal of Clinical Psychiatry, 55 (Suppl A), 55-61.
35. Pande AC and Sayler ME (1993a) Severity of depression and response to fluoxetine. International Clinical Psychopharmacology, 8, 243-245.
36. Pande AC and Sayler ME (1993b) Adverse events and treatment discontinuations in fluoxetine clinical trials. International Clinicial Psychopharmacology, 8, 267-269.
37. Paykel ES and Weissman MM (1973) Social adjustment and depression: a longitudinal study. Archives of General Psychiatry, 28, 659-663.
38. Simon G, Wagner E and Vonkorff M (1995) Cost-effectiveness comparisons using "real world" randomized trials: the case of new antidepressant drugs. Journal of Clinical Epidemiology, 48, 363-373.
39. Song F, Freemantle N, Sheldon TA et al. (1993) Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability. British Medical Journal, 306, 683-687.
40. Souêtre E, Lozet H, Martin P et al. (1993) Arrêt de travail et dépression: impact de la fluoxetine. Thérapie, 48, 81-88.
41. Stark P, Fuller RW and Wong DT (1985) The pharmacologic profile of fluoxetine. Journal of Clinical Psychiatry, 46 (3 Pt 2), 7-13.
42. Stewart AL, Hays RD and Ware JE (1988) The MOS short-form general health survey: reliability and validity in a patient population. Medical Care, 26, 724-735.
43. Stewart AL, Greenfield S, Hays RD et al. (1989) Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study. Journal of the American Medical Association, 262, 907-913.
44. Strom BL (Ed.) (1989) Pharmaco-epidemiology. Churchill Livingstone, New York.
45. Tollefson GD, Souêtre E, Thomander L et al. (1993) Co-morbid anxious signs and symptoms in major depression: impact on functional work capacity and comparative treatment outcomes. International Clinical Psychopharmacology, 8, 281-293.
46. Tollefson GD, Holman SL, Sayler ME et al. (1994) Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features. Journal of Clinical Psychiatry, 55, 50-59.
47. Tyrer P (1978) Drug treatment of psychiatric patients in general practice. British Medical Journal, 2, 1008-1010.
48. Van Dam F, Somers R et al. (1987) Quality of Life in Clinical Trials of Cardiovascular Therapies. MTP Press, London.
49. Ware JE Jr (1987) Standards for validating health measures: definition and content. Journal of Chronic Diseases, 40, 473-480.
50. Weissman MM and Bothwell (1976) Assessment of social adjustment by patient self-report. Archives of General Psychiatry, 33, 1111-1115.
51. Weissman MM, Myers JK and Thompson VD (1981) Depression and its treatment in a US urban community: 1975-1976. Archives of General Psychiatry, 38, 417-421.
52. Wells KB, Golding JM, Burman MA et al. (1988) Psychiatric disorders and limitations in physical functioning in a sample of the Los Angeles general population. American Journal of Psychiatry, 145, 712-717.
53. Wells KB, Stewart A, Hays RD et al. (1989) The functioning and well-being of depressed patients. Results from the Medical Outcomes Study. Journal of the American Medical Association, 262, 914-919.